RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers
Kyoungwha Pang,
Jinah Park,
Sung Gwe Ahn,
Jihee Lee,
Yuna Park,
Akira Ooshima,
Seiya Mizuno,
Satoshi Yamashita,
Kyung-Soon Park,
So-Young Lee,
Joon Jeong,
Toshikazu Ushijima,
Kyung-Min Yang () and
Seong-Jin Kim ()
Additional contact information
Kyoungwha Pang: Seoul National University
Jinah Park: Seoul National University
Sung Gwe Ahn: Yonsei University Medical College
Jihee Lee: Seoul National University
Yuna Park: Seoul National University
Akira Ooshima: Seoul National University
Seiya Mizuno: University of Tsukuba
Satoshi Yamashita: National Cancer Center Research Institute
Kyung-Soon Park: CHA University
So-Young Lee: CHA University
Joon Jeong: Yonsei University Medical College
Toshikazu Ushijima: National Cancer Center Research Institute
Kyung-Min Yang: Seoul National University
Seong-Jin Kim: Seoul National University
Nature Communications, 2019, vol. 10, issue 1, 1-13
Abstract:
Abstract The development of triple-negative breast cancer (TNBC) negatively impacts both quality of life and survival in a high percentage of patients. Here, we show that RING finger protein 208 (RNF208) decreases the stability of soluble Vimentin protein through a polyubiquitin-mediated proteasomal degradation pathway, thereby suppressing metastasis of TNBC cells. RNF208 was significantly lower in TNBC than the luminal type, and low expression of RNF208 was strongly associated with poor clinical outcomes. Furthermore, RNF208 was induced by 17β-estradiol (E2) treatment in an estrogen receptor alpha (ΕRα)-dependent manner. Overexpression of RNF208 suppresses tumor formation and lung metastasis of TNBC cells. Mechanistically, RNF208 specifically polyubiquitinated the Lys97 residue within the head domain of Vimentin through interaction with the Ser39 residue of phosphorylated Vimentin, which exists as a soluble form, eventually facilitating proteasomal degradation of Vimentin. Collectively, our findings define RNF208 as a negative regulator of soluble Vimentin and a prognostic biomarker for TNBC cells.
Date: 2019
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-019-13852-5 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-13852-5
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-019-13852-5
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().